Personalised Medicine and Advanced Therapies

Objectives
  • To advance precision medicine through the development of diagnostic, prognostic and predictive biomarkers (including omic signatures).
  • To apply emerging predictive and mechanistic models such as organoids and 3D bioprinting, as well as innovative gene-editing technologies (CRISPR/Cas), to the development of advanced therapies.
  • To promote the translation of basic advances into clinical practice, personalising treatments, optimising doses, avoiding toxicities and reducing adverse effects.

INCLIVA research groups involved
Coordinators

Dr Valentina Gambardella

Dra. Valentina Gambardella

Dr María José Terol

Dra. Mª José Terol Casterá